For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant ...

The drugs - which are also used to treat schizophrenia - work by mimicking the behaviour of dopamine, a natural chemical in ...

British drug companies are making a new assault on schizophrenia, with about 16 novel medicines in the pipeline. A number of experimental drugs are designed to alter the chemistry of brain regions ...

In April, the American Psychiatric Association (APA) released a comprehensive treatment guideline for treating adults who have been diagnosed with schizophrenia. Titled "The Practice Guideline for ...

They include: Neurotransmitter Dysfunction Some medicines traditionally used to treat schizophrenia are dopamine receptor antagonists, which work by blocking the effects of the neurotransmitter ...

Clozapine, which was approved in 1989, is regarded by many physicians as the most effective available treatment for schizophrenia, and research shows that the drug significantly reduces suicidal ...

In fall 2024, xanomeline trospium chloride (XT) was approved by the U.S. Food and Drug Administration for the treatment of adults with schizophrenia. In an earlier post, we reviewed evidence that this ...

A study by the US Food and Drug Administration (FDA) that looks back at clinical trials of antipsychotic drugs for schizophrenia carried out between 1991 and 2008 found that while the drugs have ...

For Boehringer, the deal adds to a broad pipeline in schizophrenia that spans both pharmacological and digital therapeutic (DTx) products. Leading the charge for new drug therapies is iclepertin ...

AI and 3D printing are being used to help in the treatment of schizophrenia in patients by helping doctors create specialized ...

giving insight into neuropsychiatric disorders, and with especial emphasis on schizophrenia.